Maxim Group Upgrades Co-Diagnostics (CODX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CODX Hot Sheet
Price: $0.37 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Join SI Premium – FREE
Maxim Group analyst Jason McCarthy upgraded Co-Diagnostics (NASDAQ: CODX) from Hold to Buy.
For an analyst ratings summary and ratings history on Co-Diagnostics click here. For more ratings news on Co-Diagnostics click here.
Shares of Co-Diagnostics closed at $18.85 yesterday.
You May Also Be Interested In
- DA Davidson Upgrades Franklin Electric (FELE) to Buy
- Northland Upgrades Coherent (COHR) to Outperform
- Fox Advisors Upgrades Plexus (PLXS) to Overweight
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
